{"entity":{"type":"insider","cik":"0001488637","url":"/insider/0001488637","json_url":"/insider/0001488637.json","name":"Sheehy Douglas T.","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":22,"n_filings":15,"first":"2010-08-11","last":"2020-01-21","span_basis":"filed_date"},"name_variants":[{"name":"Sheehy Douglas T.","source":"filing","n_filings":15,"first_seen":"2010-08-11","last_seen":"2020-01-21"}],"transactions":[{"id":2374810,"accession":"0000899243-20-001533","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000899243-20-001533","line_url":"/filing/0000899243-20-001533#line-2","is_derivative":false,"issuer_cik":"0001488637","issuer_name":"Aimmune Therapeutics, Inc.","issuer_ticker":"AIMT","issuer_name_source":null,"issuer_url":"/issuer/0001488637","owner_cik":"0001488637","owner_name":"Sheehy Douglas T.","owner_display_name":"Sheehy Douglas T.","owner_url":"/insider/0001488637","role":"Officer","role_mark":"O","role_mark_label":"Officer","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"See Remarks","security_title":"Common Stock, $0.0001 par value","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":400.0,"shares_display":"400","price_per_share":37.0,"price_display":"37.00","price_state":"stated","total_value":14800.0,"total_display":"14,800.00","total_whole":"14,800","shares_owned_after":45668.0,"shares_owned_after_display":"45,668","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-01-16","filed_date":"2020-01-21","scope":"insider"},{"id":8234539,"accession":"0000899243-19-030174","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000899243-19-030174","line_url":"/filing/0000899243-19-030174#line-2","is_derivative":false,"issuer_cik":"0001488637","issuer_name":"Aimmune Therapeutics, Inc.","issuer_ticker":"AIMT","issuer_name_source":null,"issuer_url":"/issuer/0001488637","owner_cik":"0001488637","owner_name":"Sheehy Douglas T.","owner_display_name":"Sheehy Douglas T.","owner_url":"/insider/0001488637","role":"Officer","role_mark":"O","role_mark_label":"Officer","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"See Remarks","security_title":"Common Stock, $0.0001 par value","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10000.0,"shares_display":"10,000","price_per_share":33.0322,"price_display":"33.03","price_state":"stated","total_value":330322.0,"total_display":"330,322.00","total_whole":"330,322","shares_owned_after":45668.0,"shares_owned_after_display":"45,668","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-12-26","filed_date":"2019-12-30","scope":"insider"},{"id":6849286,"accession":"0000899243-18-013932","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0000899243-18-013932","line_url":"/filing/0000899243-18-013932","is_derivative":false,"issuer_cik":"0001488637","issuer_name":"Aimmune Therapeutics, Inc.","issuer_ticker":"AIMT","issuer_name_source":null,"issuer_url":"/issuer/0001488637","owner_cik":"0001488637","owner_name":"Sheehy Douglas T.","owner_display_name":"Sheehy Douglas T.","owner_url":"/insider/0001488637","role":"Officer","role_mark":"O","role_mark_label":"Officer","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"See Remarks","security_title":"Common Stock, $0.0001 par value","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3296.0,"shares_display":"3,296","price_per_share":33.0,"price_display":"33.00","price_state":"stated","total_value":108768.0,"total_display":"108,768.00","total_whole":"108,768","shares_owned_after":33079.0,"shares_owned_after_display":"33,079","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-05-22","filed_date":"2018-05-24","scope":"insider","n_lines":2},{"id":6677711,"accession":"0000899243-18-006565","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0000899243-18-006565","line_url":"/filing/0000899243-18-006565","is_derivative":false,"issuer_cik":"0001488637","issuer_name":"Aimmune Therapeutics, Inc.","issuer_ticker":"AIMT","issuer_name_source":null,"issuer_url":"/issuer/0001488637","owner_cik":"0001488637","owner_name":"Sheehy Douglas T.","owner_display_name":"Sheehy Douglas T.","owner_url":"/insider/0001488637","role":"Officer","role_mark":"O","role_mark_label":"Officer","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"See Remarks","security_title":"Common Stock, $0.0001 par value","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3523.0,"shares_display":"3,523","price_per_share":36.521990576213454,"price_display":"36.52","price_state":"stated","total_value":128666.9728,"total_display":"128,666.97","total_whole":"128,667","shares_owned_after":32500.0,"shares_owned_after_display":"32,500","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-03-05","filed_date":"2018-03-06","scope":"insider","n_lines":3},{"id":6381024,"accession":"0000899243-18-003090","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000899243-18-003090","line_url":"/filing/0000899243-18-003090#line-2","is_derivative":false,"issuer_cik":"0001488637","issuer_name":"Aimmune Therapeutics, Inc.","issuer_ticker":"AIMT","issuer_name_source":null,"issuer_url":"/issuer/0001488637","owner_cik":"0001488637","owner_name":"Sheehy Douglas T.","owner_display_name":"Sheehy Douglas T.","owner_url":"/insider/0001488637","role":"Officer","role_mark":"O","role_mark_label":"Officer","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"See Remarks","security_title":"Common Stock, $0.0001 par value","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1648.0,"shares_display":"1,648","price_per_share":35.87,"price_display":"35.87","price_state":"stated","total_value":59113.76,"total_display":"59,113.76","total_whole":"59,114","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-02-05","filed_date":"2018-02-07","scope":"insider"},{"id":6772513,"accession":"0000899243-18-002125","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000899243-18-002125","line_url":"/filing/0000899243-18-002125#line-2","is_derivative":false,"issuer_cik":"0001488637","issuer_name":"Aimmune Therapeutics, Inc.","issuer_ticker":"AIMT","issuer_name_source":null,"issuer_url":"/issuer/0001488637","owner_cik":"0001488637","owner_name":"Sheehy Douglas T.","owner_display_name":"Sheehy Douglas T.","owner_url":"/insider/0001488637","role":"Officer","role_mark":"O","role_mark_label":"Officer","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"See Remarks","security_title":"Common Stock, $0.0001 par value","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1875.0,"shares_display":"1,875","price_per_share":38.15,"price_display":"38.15","price_state":"stated","total_value":71531.25,"total_display":"71,531.25","total_whole":"71,531","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-01-24","filed_date":"2018-01-26","scope":"insider"},{"id":6716727,"accession":"0000899243-18-000671","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000899243-18-000671","line_url":"/filing/0000899243-18-000671#line-2","is_derivative":false,"issuer_cik":"0001488637","issuer_name":"Aimmune Therapeutics, Inc.","issuer_ticker":"AIMT","issuer_name_source":null,"issuer_url":"/issuer/0001488637","owner_cik":"0001488637","owner_name":"Sheehy Douglas T.","owner_display_name":"Sheehy Douglas T.","owner_url":"/insider/0001488637","role":"Officer","role_mark":"O","role_mark_label":"Officer","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"See Remarks","security_title":"Common Stock, $0.0001 par value","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1648.0,"shares_display":"1,648","price_per_share":37.33,"price_display":"37.33","price_state":"stated","total_value":61519.84,"total_display":"61,519.84","total_whole":"61,520","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-01-04","filed_date":"2018-01-08","scope":"insider"},{"id":5158079,"accession":"0000899243-17-029678","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000899243-17-029678","line_url":"/filing/0000899243-17-029678#line-2","is_derivative":false,"issuer_cik":"0001488637","issuer_name":"Aimmune Therapeutics, Inc.","issuer_ticker":"AIMT","issuer_name_source":null,"issuer_url":"/issuer/0001488637","owner_cik":"0001488637","owner_name":"Sheehy Douglas T.","owner_display_name":"Sheehy Douglas T.","owner_url":"/insider/0001488637","role":"Officer","role_mark":"O","role_mark_label":"Officer","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"See Remarks","security_title":"Common Stock, $0.0001 par value","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1875.0,"shares_display":"1,875","price_per_share":39.44,"price_display":"39.44","price_state":"stated","total_value":73950.0,"total_display":"73,950.00","total_whole":"73,950","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-12-26","filed_date":"2017-12-28","scope":"insider"},{"id":5010288,"accession":"0000899243-17-028062","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000899243-17-028062","line_url":"/filing/0000899243-17-028062#line-2","is_derivative":false,"issuer_cik":"0001488637","issuer_name":"Aimmune Therapeutics, Inc.","issuer_ticker":"AIMT","issuer_name_source":null,"issuer_url":"/issuer/0001488637","owner_cik":"0001488637","owner_name":"Sheehy Douglas T.","owner_display_name":"Sheehy Douglas T.","owner_url":"/insider/0001488637","role":"Officer","role_mark":"O","role_mark_label":"Officer","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"See Remarks","security_title":"Common Stock, $0.0001 par value","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1906.0,"shares_display":"1,906","price_per_share":38.66,"price_display":"38.66","price_state":"stated","total_value":73685.96,"total_display":"73,685.96","total_whole":"73,686","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-12-04","filed_date":"2017-12-06","scope":"insider"},{"id":4524431,"accession":"0000899243-17-027853","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000899243-17-027853","line_url":"/filing/0000899243-17-027853#line-2","is_derivative":false,"issuer_cik":"0001488637","issuer_name":"Aimmune Therapeutics, Inc.","issuer_ticker":"AIMT","issuer_name_source":null,"issuer_url":"/issuer/0001488637","owner_cik":"0001488637","owner_name":"Sheehy Douglas T.","owner_display_name":"Sheehy Douglas T.","owner_url":"/insider/0001488637","role":"Officer","role_mark":"O","role_mark_label":"Officer","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"See Remarks","security_title":"Common Stock, $0.0001 par value","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3750.0,"shares_display":"3,750","price_per_share":37.0,"price_display":"37.00","price_state":"stated","total_value":138750.0,"total_display":"138,750.00","total_whole":"138,750","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-11-30","filed_date":"2017-12-04","scope":"insider"},{"id":4352268,"accession":"0000899243-17-026085","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000899243-17-026085","line_url":"/filing/0000899243-17-026085#line-2","is_derivative":false,"issuer_cik":"0001488637","issuer_name":"Aimmune Therapeutics, Inc.","issuer_ticker":"AIMT","issuer_name_source":null,"issuer_url":"/issuer/0001488637","owner_cik":"0001488637","owner_name":"Sheehy Douglas T.","owner_display_name":"Sheehy Douglas T.","owner_url":"/insider/0001488637","role":"Officer","role_mark":"O","role_mark_label":"Officer","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"See Remarks","security_title":"Common Stock, $0.0001 par value","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1905.0,"shares_display":"1,905","price_per_share":33.0,"price_display":"33.00","price_state":"stated","total_value":62865.0,"total_display":"62,865.00","total_whole":"62,865","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-11-09","filed_date":"2017-11-13","scope":"insider"},{"id":4691745,"accession":"0000899243-17-024682","txn_seq":7,"anchor":"line-7","filing_url":"/filing/0000899243-17-024682","line_url":"/filing/0000899243-17-024682","is_derivative":false,"issuer_cik":"0001488637","issuer_name":"Aimmune Therapeutics, Inc.","issuer_ticker":"AIMT","issuer_name_source":null,"issuer_url":"/issuer/0001488637","owner_cik":"0001488637","owner_name":"Sheehy Douglas T.","owner_display_name":"Sheehy Douglas T.","owner_url":"/insider/0001488637","role":"Officer","role_mark":"O","role_mark_label":"Officer","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"See Remarks","security_title":"Common Stock, $0.0001 par value","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":47425.0,"shares_display":"47,425","price_per_share":34.444153967316815,"price_display":"34.44","price_state":"stated","total_value":1633514.0019,"total_display":"1,633,514.00","total_whole":"1,633,514","shares_owned_after":11336.0,"shares_owned_after_display":"11,336","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-10-23","filed_date":"2017-10-25","scope":"insider","n_lines":5},{"id":4351621,"accession":"0000899243-17-018723","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899243-17-018723","line_url":"/filing/0000899243-17-018723#line-1","is_derivative":false,"issuer_cik":"0001488637","issuer_name":"Aimmune Therapeutics, Inc.","issuer_ticker":"AIMT","issuer_name_source":null,"issuer_url":"/issuer/0001488637","owner_cik":"0001488637","owner_name":"Sheehy Douglas T.","owner_display_name":"Sheehy Douglas T.","owner_url":"/insider/0001488637","role":"Officer","role_mark":"O","role_mark_label":"Officer","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"See Remarks","security_title":"Common Stock, $0.0001 par value","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":7460.0,"shares_display":"7,460","price_per_share":21.6566,"price_display":"21.66","price_state":"stated","total_value":161558.236,"total_display":"161,558.24","total_whole":"161,558","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-07-21","filed_date":"2017-07-21","scope":"insider"},{"id":2090475,"accession":"0001181431-12-050641","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001181431-12-050641","line_url":"/filing/0001181431-12-050641#line-1","is_derivative":false,"issuer_cik":"0001200375","issuer_name":"CODEXIS INC","issuer_ticker":"CDXS","issuer_name_source":null,"issuer_url":"/issuer/0001200375","owner_cik":"0001488637","owner_name":"Sheehy Douglas T.","owner_display_name":"Sheehy Douglas T.","owner_url":"/insider/0001488637","role":"Officer (SVP, General Counsel & Sec)","role_mark":"O","role_mark_label":"Officer (SVP, General Counsel & Sec)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP, General Counsel & Sec.","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3800.0,"shares_display":"3,800","price_per_share":2.7633,"price_display":"2.76","price_state":"stated","total_value":10500.54,"total_display":"10,500.54","total_whole":"10,501","shares_owned_after":69200.0,"shares_owned_after_display":"69,200","ownership_form":"D","is_10b5_1":null,"transaction_date":"2012-09-14","filed_date":"2012-09-14","scope":"insider"},{"id":7195822,"accession":"0001181431-10-041499","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001181431-10-041499","line_url":"/filing/0001181431-10-041499#line-1","is_derivative":false,"issuer_cik":"0001200375","issuer_name":"CODEXIS INC","issuer_ticker":"CDXS","issuer_name_source":null,"issuer_url":"/issuer/0001200375","owner_cik":"0001488637","owner_name":"Sheehy Douglas T.","owner_display_name":"Sheehy Douglas T.","owner_url":"/insider/0001488637","role":"Officer (SVP, Gen Counsel and Sec)","role_mark":"O","role_mark_label":"Officer (SVP, Gen Counsel and Sec)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP, Gen Counsel and Sec.","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1000.0,"shares_display":"1,000","price_per_share":7.986,"price_display":"7.99","price_state":"stated","total_value":7986.0,"total_display":"7,986.00","total_whole":"7,986","shares_owned_after":1000.0,"shares_owned_after_display":"1,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2010-08-10","filed_date":"2010-08-11","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":22,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":1,"open_market":true},{"code":"S","label":"Open-market sale","n":21,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":22},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001631650","name":"Aimmune Therapeutics, Inc.","url":"/issuer/0001631650","role":"Officer","n_filings":13,"first_seen":"2017-07-21","last_seen":"2020-01-21"},{"type":"issuer","type_label":"ISSUER","cik":"0001200375","name":"CODEXIS INC","url":"/issuer/0001200375","role":"Officer (SVP, General Counsel & Sec)","n_filings":2,"first_seen":"2010-08-11","last_seen":"2012-09-14"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001488637","retrieved_at":"2026-08-25T18:48:22+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-24","last_ingest":"2026-08-25T05:24:19.374141+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}